Diphtheria
A serious bacterial disease that most often affects the nose and throat and can release a toxin that damages the heart, nerves, kidneys, and other organs.
What causes Diphtheria?
Diphtheria is caused mainly by toxin-producing Corynebacterium diphtheriae bacteria. It commonly spreads through respiratory droplets or close contact and can also spread through contact with infected skin sores or contaminated objects.
Symptoms and what to notice
Sore throat, low fever, weakness, swollen neck glands, trouble swallowing, hoarseness, and a thick gray or white throat membrane are typical of respiratory disease. Skin diphtheria can cause slow-healing sores or ulcers.
How long can it last?
Symptoms usually begin 2 to 5 days after exposure, with a possible range of 1 to 10 days. Recovery can take weeks, especially when toxin-related heart or nerve complications occur. Patients can remain infectious until effective antibiotics and follow-up testing confirm clearance.
How serious is Diphtheria?
Respiratory diphtheria can obstruct the airway and cause myocarditis, abnormal heart rhythms, nerve paralysis, kidney injury, or death. The overall case-fatality rate is about 5% to 10% and can reach about 20% in children younger than 5 and adults older than 40.
Treatment and management
Suspected respiratory diphtheria is a medical emergency. Diphtheria antitoxin should be given promptly without waiting for laboratory confirmation, together with erythromycin or penicillin, respiratory isolation, airway and cardiac monitoring, supportive care, and public-health coordination.
Vaccine: who and when?
Products: DTaP vaccines for children include Daptacel and Infanrix, plus combination vaccines Kinrix, Pediarix, Pentacel, Quadracel, and Vaxelis. Tdap products are Adacel and Boostrix, and Tenivac is a Td product. CDC recommends DTaP at ages 2, 4, and 6 months, 15-18 months, and 4-6 years; Tdap at 11-12 years; Tdap once for adults who never received it followed by Td or Tdap every 10 years; and Tdap during every pregnancy, preferably early in weeks 27-36.
Cost note: Patient cost varies by product, provider, insurance, and eligibility. U.S. routine vaccines are commonly covered without cost sharing when given by an in-network provider, and eligible children can receive vaccines through the Vaccines for Children program.
Trusted source
Patient cost varies by insurance, provider, location, and eligibility. Coverage and public-health access differ, so listed prices are examples rather than guaranteed patient prices. This page is for general education and does not replace individualized medical advice, diagnosis, vaccination assessment, or treatment.
Diphtheria: History, Symptoms, Transmission, Treatment, Prevention, and Vaccine Information
Diphtheria is a serious and potentially fatal bacterial disease caused primarily by toxin-producing strains of Corynebacterium diphtheriae.
The infection most commonly affects the nose and throat, although the bacteria can also infect the skin. Respiratory diphtheria is the most dangerous form because the bacteria can produce a powerful toxin that damages local tissues and may spread through the bloodstream to injure the heart, nerves, kidneys, and other organs.
One of the most recognizable signs of respiratory diphtheria is a thick gray or whitish coating in the throat known as a pseudomembrane. This membrane can become firmly attached to the tissues of the throat and may interfere with breathing and swallowing.
Typical early symptoms include:
- Sore throat
- Mild fever
- Difficulty swallowing
- Weakness
- Loss of appetite
- Swollen glands in the neck
- Hoarseness
- A thick gray pseudomembrane in the nose or throat
Severe swelling of the neck can produce the historically recognized appearance known as “bull neck.”
Diphtheria was once one of the most feared childhood infections in the world. Before widespread vaccination, large epidemics caused enormous numbers of illnesses and deaths, particularly among children.
Vaccination transformed the situation dramatically. Diphtheria is now extremely uncommon in the United States, but it has not been eradicated globally. Outbreaks continue to occur, particularly where vaccination coverage is low or healthcare systems have been disrupted. (who.int)
WHO reported that approximately 85% of infants worldwide received three doses of diphtheria-containing vaccine in 2025, leaving nearly 20 million children with no vaccination or incomplete protection. (who.int)
The disease remains dangerous because treatment must begin quickly. Even with modern medical care, respiratory diphtheria can cause airway obstruction, myocarditis, nerve damage, and death.
Important: This article provides general educational information and does not replace diagnosis, emergency treatment, vaccination advice, or medical care from a qualified healthcare professional.
What Is Diphtheria?
Diphtheria is an acute bacterial disease caused mainly by toxin-producing strains of:
Corynebacterium diphtheriae
The bacterium is an aerobic, gram-positive bacillus.
However, an important distinction is necessary.
Not every C. diphtheriae bacterium produces diphtheria toxin.
The serious disease traditionally called diphtheria occurs when the bacteria acquire the ability to produce a powerful exotoxin.
The toxin, rather than the bacteria spreading throughout the body, is responsible for many of the most dangerous systemic complications.
CDC describes diphtheria as disease caused by toxin-producing C. diphtheriae. Nontoxigenic strains can also cause infections, including pharyngitis, bloodstream infection, endocarditis, and other illnesses, but these are clinically different from classic toxin-mediated diphtheria. (cdc.gov)
Diphtheria Quick Facts
| Feature | Information |
|---|---|
| Disease | Diphtheria |
| Main cause | Toxin-producing Corynebacterium diphtheriae |
| Organism type | Gram-positive bacterium |
| Main transmission | Respiratory droplets and close contact |
| Other form | Cutaneous diphtheria |
| Typical incubation period | 2 to 5 days |
| Possible incubation range | Approximately 1 to 10 days |
| Hallmark respiratory sign | Thick adherent pseudomembrane |
| Major toxin complications | Myocarditis and nerve damage |
| Overall case-fatality rate | Approximately 5% to 10% |
| Highest mortality groups | Children under 5 and adults over 40 |
| Main treatment | Diphtheria antitoxin plus antibiotics |
| Recommended antibiotics in U.S. guidance | Erythromycin or penicillin |
| Vaccine available | Yes |
| Childhood vaccine | DTaP |
| Adolescent and adult vaccines | Tdap and Td |
| Adult booster interval | Every 10 years |
| Pregnancy | Tdap during every pregnancy |
| U.S. status | Rare and nationally notifiable |
| Global status | Continued circulation and outbreaks |
CDC estimates the overall case-fatality rate of diphtheria at approximately 5% to 10%, with rates reaching about 20% among children younger than 5 years and adults older than 40 years. (cdc.gov)
The History of Diphtheria
Diphtheria has an unusually important place in medical history.
Research into diphtheria helped scientists understand:
- Bacterial toxins
- Passive immunity
- Antibodies
- Antitoxin therapy
- Toxoid vaccines
- Laboratory diagnosis
- Vaccine standardization
The disease contributed directly to the birth of modern immunology.
Ancient Descriptions of Diphtheria
Diphtheria-like disease has been recognized for more than two thousand years.
CDC’s historical review notes that Hippocrates described the disease during the fifth century BCE.
Descriptions of epidemics also appeared during the sixth century CE. (cdc.gov)
Ancient physicians could recognize the frightening throat disease but had no understanding of bacteria or toxins.
Patients could develop:
- Severe throat inflammation
- Thick membranes
- Difficulty breathing
- Paralysis
- Sudden cardiac complications
- Death
Children were particularly vulnerable.
Where Did the Name Diphtheria Come From?
The word diphtheria comes from the Greek word:
diphthera
meaning approximately:
leather or hide
The name refers to the thick, tough membrane that can form across the throat.
This pseudomembrane became one of the most recognizable features of the disease.
Diphtheria Was Once Called “The Strangling Angel”
Before vaccination and antitoxin treatment, diphtheria was especially feared because children could gradually lose their ability to breathe as the membrane and surrounding swelling obstructed the airway.
Historical descriptions referred to diphtheria using names related to suffocation or strangulation.
The disease became known in popular language as the “strangling angel of children.”
The name reflected the frightening progression of severe respiratory disease rather than a formal medical term.
1826: Pierre Bretonneau Defines Diphtheria as a Distinct Disease
French physician Pierre Bretonneau made major contributions to distinguishing diphtheria from other throat infections during the early nineteenth century.
He recognized that the characteristic throat membrane represented a particular disease process rather than simply a severe form of other throat illnesses.
Bretonneau introduced terminology derived from the Greek word diphthera.
This helped establish diphtheria as a distinct clinical disease.
1883: Edwin Klebs Observes the Bacterium
Modern understanding of diphtheria began in the late nineteenth century.
In 1883, German-Swiss pathologist Edwin Klebs observed characteristic bacteria within diphtheritic throat membranes.
This was an important clue that a specific microorganism caused the disease. (cdc.gov)
1884: Friedrich Löffler Cultivates the Organism
The following year, Friedrich Löffler successfully cultivated the bacterium.
The organism consequently became historically known as the Klebs-Löffler bacillus.
Löffler made another important observation.
The bacteria appeared to remain primarily around the site of infection rather than invading every distant organ that became damaged.
He proposed that the bacteria must release a soluble poison capable of traveling through the body.
That hypothesis proved correct.
1888: Roux and Yersin Demonstrate Diphtheria Toxin
French scientists Émile Roux and Alexandre Yersin provided experimental evidence that the bacteria released a powerful toxin.
They filtered bacterial cultures so that the bacteria themselves were removed.
The remaining bacteria-free fluid could still produce serious disease and organ injury when introduced into experimental animals.
This demonstrated that a secreted toxin, rather than widespread bacterial invasion, caused many of diphtheria’s systemic effects. (ncbi.nlm.nih.gov)
This discovery fundamentally changed the understanding of bacterial disease.
Scientists now knew that bacteria could cause severe illness not only by invading tissues but also by producing powerful chemical toxins.
1890: Diphtheria Antitoxin Is Developed
Another revolutionary discovery followed.
In 1890, Emil von Behring and researchers working in the emerging field of serum therapy demonstrated that blood serum from immunized animals could contain substances capable of neutralizing bacterial toxins.
Von Behring’s work on diphtheria, alongside the related work of Shibasaburo Kitasato on tetanus, helped establish the scientific concept of antitoxins and passive immunity. (nobelprize.org)
An animal could be gradually exposed to toxin.
Its immune system would produce substances that neutralized the toxin.
Serum containing these antitoxins could then be transferred to another individual.
This was one of the earliest successful forms of antibody therapy.
1891: A Child Is Successfully Treated With Antitoxin
The first successful therapeutic use of diphtheria antitoxin in a sick child occurred in 1891.
Further clinical experience during the 1890s demonstrated that early antitoxin treatment could dramatically reduce mortality. (nobelprize.org)
Large animals, particularly horses, became important sources of therapeutic antitoxin because they could produce sufficient quantities of serum.
1894: Antitoxin Becomes a Major Medical Treatment
By the mid-1890s, diphtheria antitoxin was being introduced into clinical practice.
Studies in Paris and elsewhere documented substantially lower death rates among children treated with antitoxin compared with earlier patients treated without it.
This represented one of medicine’s first major demonstrations that laboratory immunology could produce a treatment capable of changing the outcome of an infectious disease.
1901: The First Nobel Prize in Medicine
In 1901, Emil von Behring received the first Nobel Prize in Physiology or Medicine.
The award specifically recognized his work on serum therapy, particularly its application against diphtheria. (nobelprize.org)
This reflects the extraordinary significance of diphtheria research to the development of immunology.
Antitoxin Was Treatment, Not Permanent Vaccination
Antitoxin was revolutionary, but it had an important limitation.
It provided passive immunity.
The antibodies came from another source and gradually disappeared.
Antitoxin could help neutralize toxin during acute disease, but it did not necessarily train the patient’s immune system to provide durable protection.
Scientists therefore continued searching for a reliable method of active immunization.
Early Toxin-Antitoxin Vaccines
During the early twentieth century, scientists experimented with mixtures containing carefully balanced diphtheria toxin and antitoxin.
These preparations could stimulate immunity but were more complicated and potentially less predictable than modern vaccines.
A safer approach eventually emerged.
The Development of Diphtheria Toxoid
Scientists discovered that diphtheria toxin could be chemically treated so that it lost its ability to cause disease while retaining its ability to stimulate an immune response.
The resulting substance became known as:
diphtheria toxoid
A toxoid is an inactivated bacterial toxin.
The immune system can learn to recognize the toxoid and produce antibodies that neutralize the active toxin during future exposure.
Diphtheria toxoid was developed during the 1920s. (cdc.gov)
1930s: Diphtheria Vaccination Expands
Diphtheria toxoid became increasingly widely used during the 1930s.
Mass childhood vaccination led to major reductions in:
- Disease
- Epidemics
- Complications
- Childhood deaths
This marked the beginning of the transformation of diphtheria from a common childhood killer into a preventable disease.
1940s: Routine Childhood Vaccination Becomes Established
Diphtheria vaccination became a routine part of childhood immunization programs in the United States during the 1940s.
Diphtheria toxoid was eventually combined with:
- Tetanus toxoid
- Pertussis vaccine
This produced the combined DTP vaccine.
Modern U.S. childhood vaccines now use acellular pertussis components and are known as DTaP.
(cdc.gov)
Vaccination Changes Diphtheria Epidemiology
Before widespread vaccination, diphtheria was a major childhood disease.
After routine vaccination was established, incidence dropped dramatically.
Today, classic respiratory diphtheria is extremely uncommon in the United States.
However, the bacteria continue circulating in other parts of the world.
Travel-associated infections can therefore still occur, and communities with low vaccination coverage remain vulnerable.
The Global Diphtheria Resurgence
Diphtheria has repeatedly demonstrated that it can return when population immunity declines.
Large outbreaks occurred in the former Soviet Union during the 1990s after vaccination coverage deteriorated.
More recently, outbreaks have occurred in regions affected by:
- Conflict
- Population displacement
- Disrupted healthcare systems
- Low routine immunization coverage
- Overcrowding
- Vaccine access problems
WHO emphasizes that no region of the world can be considered completely free from diphtheria risk when immunity gaps persist. (who.int)
What Causes Diphtheria?
The principal cause is toxin-producing:
Corynebacterium diphtheriae
However, two related species can occasionally produce the same diphtheria toxin:
- Corynebacterium ulcerans
- Corynebacterium pseudotuberculosis
Toxin-producing C. ulcerans can cause respiratory disease resembling classic diphtheria.
Unlike C. diphtheriae, C. ulcerans can be associated with animal exposure, and documented person-to-person transmission has not been established in the same way. (cdc.gov)
What Is Corynebacterium diphtheriae?
C. diphtheriae is a:
- Gram-positive
- Aerobic
- Non-spore-forming
- Rod-shaped bacterium
Several traditional biotypes have been described, including:
- Gravis
- Mitis
- Intermedius
- Belfanti
All isolates relevant to suspected diphtheria must be evaluated for toxin production because identifying C. diphtheriae alone does not prove that the strain produces diphtheria toxin. (cdc.gov)
Why Do Only Some Diphtheria Bacteria Produce Toxin?
This is one of the most fascinating aspects of diphtheria biology.
A C. diphtheriae bacterium generally becomes toxigenic after infection with a particular type of virus that infects bacteria.
Such viruses are called:
bacteriophages
The bacteriophage carries the tox gene, which contains the genetic instructions necessary for production of diphtheria toxin.
In other words, a virus infects the bacterium and provides the genetic information that allows the bacterium to produce one of medicine’s most famous bacterial toxins. (cdc.gov)
What Does Diphtheria Toxin Do?
Diphtheria toxin enters susceptible human cells and interferes with protein synthesis.
Without the ability to manufacture essential proteins, affected cells become injured and may die.
At the infection site, this contributes to:
- Tissue destruction
- Inflammation
- Formation of the pseudomembrane
The toxin can also enter the bloodstream and reach distant organs.
Important targets include:
- Heart
- Peripheral nerves
- Kidneys
(cdc.gov)
This explains why someone with an infection concentrated in the throat can later develop heart failure or paralysis.
How Does Diphtheria Spread?
Toxin-producing C. diphtheriae spreads mainly from one person to another.
Transmission occurs primarily through:
- Respiratory droplets
- Close physical contact
- Contact with respiratory secretions
- Contact with infected skin lesions
An infected person can release bacteria when coughing or sneezing.
People living in close proximity are at increased risk.
Can Someone Without Symptoms Spread Diphtheria?
Yes.
Some people can carry C. diphtheriae without developing obvious disease.
These carriers can still potentially transmit the bacteria to others.
This makes laboratory testing and management of close contacts important during a diphtheria investigation. (who.int)
Can Diphtheria Spread Through Skin Contact?
Yes.
Cutaneous diphtheria involves infection of the skin.
Direct contact with infected wounds or contaminated secretions can contribute to transmission.
Healthcare workers caring for cutaneous cases therefore use contact precautions until the patient has completed appropriate treatment and cultures confirm that the bacteria have been eliminated. (cdc.gov)
What Is the Incubation Period?
Symptoms usually begin approximately:
2 to 5 days after exposure
The possible incubation period is approximately:
1 to 10 days
(cdc.gov)
What Are the Main Types of Diphtheria?
Diphtheria can involve several anatomical sites.
The most important forms are:
- Pharyngeal and tonsillar diphtheria
- Laryngeal diphtheria
- Nasal diphtheria
- Cutaneous diphtheria
Rarely, other mucous membranes can also become infected.
What Is Respiratory Diphtheria?
Respiratory diphtheria develops when toxigenic bacteria infect the nose, throat, tonsils, larynx, or nearby respiratory structures.
It is the classic and most dangerous form.
Symptoms generally begin gradually rather than suddenly.
Common symptoms include:
- Mild fever
- Sore throat
- Malaise
- Loss of appetite
- Difficulty swallowing
- Enlarged neck lymph nodes
- Weakness
(cdc.gov)
The characteristic pseudomembrane usually develops after the initial symptoms.
What Is the Diphtheria Pseudomembrane?
The pseudomembrane is the hallmark finding of respiratory diphtheria.
It is a thick layer containing:
- Dead tissue
- Fibrin
- Inflammatory cells
- Bacteria
- Cellular debris
It can appear:
- Gray
- Gray-white
- Greenish-gray
The membrane may cover the:
- Tonsils
- Pharynx
- Larynx
- Nose
- Trachea in severe disease
CDC reports that the pseudomembrane often appears within approximately 2 to 3 days of illness. (cdc.gov)
Why Should the Pseudomembrane Not Be Forcefully Removed?
Unlike an ordinary coating from some throat infections, the diphtheria pseudomembrane is firmly attached to underlying tissue.
Trying to scrape or remove it can cause:
- Bleeding
- Tissue injury
- Airway complications
Its strongly adherent nature is an important clinical clue.
What Is “Bull Neck” Diphtheria?
Severe pharyngeal diphtheria can cause substantial swelling of:
- Neck tissues
- Cervical lymph nodes
This can create a broad, swollen neck known as:
bull neck
Bull-neck appearance is associated with extensive local disease and can indicate serious infection.
What Is Laryngeal Diphtheria?
When the larynx becomes involved, symptoms may include:
- Hoarseness
- Barking cough
- Noisy breathing
- Stridor
- Progressive breathing difficulty
The combination of swelling and pseudomembrane formation can obstruct the airway.
Airway obstruction is one of the most immediately life-threatening complications of diphtheria.
What Is Nasal Diphtheria?
Nasal diphtheria can cause:
- Nasal discharge
- Irritation
- Crusting
- Membrane formation
The illness may be less dramatic than pharyngeal diphtheria but can still allow transmission.
What Is Cutaneous Diphtheria?
Cutaneous diphtheria occurs when C. diphtheriae infects damaged skin.
Symptoms may include:
- Chronic ulcer
- Open sore
- Clearly defined edges
- Pain
- Redness
- Swelling
- Scaling
- Peeling skin
- Grayish membrane
The wounds may heal slowly. (cdc.gov)
Systemic toxin-related complications are less common with cutaneous disease than respiratory diphtheria.
Can Diphtheria Affect Other Parts of the Body?
Rare infections can involve other mucous membranes, including the:
- Eye conjunctiva
- External ear canal
- Genital tract
These presentations are much less common.
Why Is Respiratory Diphtheria So Dangerous?
Two major processes occur simultaneously.
First, local disease can obstruct the airway.
Second, circulating toxin can damage organs far from the original throat infection.
The most dangerous complications include:
- Airway obstruction
- Myocarditis
- Polyneuropathy
- Kidney injury
- Respiratory failure
- Death
(cdc.gov)
What Is Diphtheria Myocarditis?
Myocarditis means inflammation and injury of the heart muscle.
Diphtheria toxin can damage cardiac cells.
Myocarditis may cause:
- Abnormal heart rhythm
- Weak heart contractions
- Heart failure
- Circulatory collapse
- Sudden death
Myocarditis can appear during the early illness or several weeks later. (cdc.gov)
Early severe myocarditis is particularly dangerous.
How Does Diphtheria Affect the Nervous System?
Diphtheria toxin can damage peripheral nerves.
This complication is sometimes called:
- Neuritis
- Polyneuritis
- Polyneuropathy
Neurological problems can appear weeks after the throat infection begins.
Possible manifestations include:
- Soft-palate paralysis
- Difficulty swallowing
- Nasal speech
- Eye-muscle weakness
- Limb weakness
- Reduced reflexes
- Diaphragm paralysis
(cdc.gov)
Can Diphtheria Cause Paralysis?
Yes.
Nerve damage can produce temporary or sometimes prolonged paralysis.
Paralysis of the soft palate is one of the more characteristic neurological complications.
More extensive neuropathy can involve:
- Arms
- Legs
- Eye muscles
- Respiratory muscles
If the diaphragm becomes paralyzed, respiratory failure can develop.
Can Diphtheria Damage the Kidneys?
Yes.
Diphtheria toxin can contribute to kidney injury.
Severe illness may be associated with:
- Nephritis
- Reduced kidney function
- Kidney failure
CDC lists kidney failure among the serious systemic complications of respiratory diphtheria. (cdc.gov)
Can Diphtheria Cause Low Platelets?
Yes.
Diphtheria toxin has also been associated with thrombocytopenia, meaning a reduced platelet count.
This is less famous than myocarditis and neuropathy but reflects the systemic effects of severe toxin-mediated disease.
How Deadly Is Diphtheria?
Diphtheria remains potentially fatal even with modern medical care.
CDC estimates the overall case-fatality rate at approximately:
5% to 10%
Death rates can reach approximately:
20%
among children younger than 5 and adults older than 40. (cdc.gov)
WHO reports that among unvaccinated people without proper treatment, fatality can be around 30%, with young children facing particularly high risk. (who.int)
The risk rises when access to antitoxin and intensive supportive care is delayed.
Why Does Early Treatment Matter So Much?
Diphtheria antitoxin can neutralize toxin that is still circulating in the bloodstream.
It cannot reverse toxin that has already attached to and entered tissues.
Therefore:
the earlier antitoxin is given, the more toxin can potentially be neutralized before permanent tissue injury occurs.
CDC specifically recommends beginning treatment for suspected respiratory diphtheria without waiting for definitive laboratory confirmation. (cdc.gov)
Who Is Most at Risk of Diphtheria?
Anyone without adequate immunity can become infected.
Risk is especially important among:
- Unvaccinated children
- Under-vaccinated children
- Adults who have not maintained booster vaccination
- Household contacts of infected people
- Healthcare workers exposed without appropriate protection
- Travelers to regions with active transmission
- People living in communities with poor vaccine coverage
- Displaced populations
- People living in overcrowded settings
WHO emphasizes that breakdowns in routine immunization, conflict, natural disasters, and weakened healthcare infrastructure can create conditions for outbreaks. (who.int)
Does Vaccination Protection Last Forever?
No.
Protection decreases over time.
CDC states that diphtheria-containing vaccines protect nearly 97 out of 100 fully vaccinated people for up to approximately 10 years. (cdc.gov)
This is why booster vaccination is recommended throughout life.
Can a Vaccinated Person Still Get Diphtheria?
Yes, although vaccination substantially reduces the risk.
No vaccine is perfectly effective.
Protection can also decline over time if booster doses are missed.
However, widespread vaccination dramatically reduces both individual risk and the ability of diphtheria to circulate through communities.
Can Someone Get Diphtheria More Than Once?
Potentially, yes.
An important and somewhat unusual feature of diphtheria is that having the disease does not reliably produce lifelong immunity.
CDC recommends reviewing vaccination status after recovery.
Patients who are not fully protected should receive an appropriate diphtheria toxoid-containing vaccine during convalescence. (cdc.gov)
Recovering from diphtheria is therefore not considered a substitute for vaccination.
How Is Diphtheria Diagnosed?
Diphtheria is partly a clinical diagnosis.
A doctor should suspect respiratory diphtheria when a patient has findings such as:
- Sore throat
- Low fever
- Swollen neck
- Adherent pseudomembrane
- Airway symptoms
- Relevant travel or exposure history
Because treatment delay can be dangerous, clinicians should not wait for complete laboratory confirmation before beginning appropriate therapy when respiratory diphtheria is strongly suspected. (cdc.gov)
What Samples Are Collected?
Specimens may be collected from:
- Throat
- Nose
- Pseudomembrane
- Skin lesions
Samples should ideally be collected before antibiotic therapy begins, although treatment should never be dangerously delayed just to obtain a specimen. (cdc.gov)
What Does Bacterial Culture Show?
The laboratory attempts to grow and identify C. diphtheriae.
However, identifying the bacteria is only the first step.
The isolate must then be evaluated for its ability to produce toxin.
Why Is Toxin Testing Necessary?
A patient can carry or become infected with C. diphtheriae that does not produce diphtheria toxin.
Therefore:
detecting the bacterium does not automatically confirm toxin-mediated diphtheria.
Specialized testing is required to determine whether the isolate is toxigenic.
CDC provides specialized confirmatory testing support in the United States. (cdc.gov)
Can PCR Detect Diphtheria?
PCR can detect genetic material including the diphtheria tox gene.
This can provide useful supporting evidence.
However, detection of the tox gene alone does not necessarily prove that the bacteria are actively producing toxin.
Culture and toxigenicity testing therefore remain important components of definitive public-health investigation.
What Is the Elek Test?
The Elek test is a classical laboratory method used to determine whether an isolate produces diphtheria toxin.
It is an immunoprecipitation assay in which toxin produced by bacteria interacts with diphtheria antitoxin.
Modern public-health laboratories may combine molecular and phenotypic testing to establish whether an isolate is toxigenic.
Should Diphtheria Treatment Wait for Test Results?
No.
When respiratory diphtheria is clinically suspected, treatment should begin promptly.
CDC explicitly recommends presumptive treatment before confirmatory test results are available when respiratory diphtheria is suspected. (cdc.gov)
This is one of the most important clinical principles in diphtheria management.
How Is Diphtheria Treated?
Respiratory diphtheria requires two major forms of therapy:
- Diphtheria antitoxin
- Antibiotics
Supportive hospital care may also be necessary.
What Is Diphtheria Antitoxin?
Diphtheria antitoxin, commonly abbreviated DAT, contains antibodies capable of neutralizing circulating diphtheria toxin.
Modern DAT used in the United States is produced from horse serum.
The treatment does not directly kill the bacteria.
Instead, it neutralizes toxin that has not yet permanently attached to tissues.
(cdc.gov)
Why Must Antitoxin Be Given Early?
Once diphtheria toxin enters and damages a cell, antitoxin cannot reverse that injury.
DAT can only neutralize toxin that remains accessible in circulation.
Therefore, every delay can allow additional toxin to bind to tissues.
This is why suspected respiratory diphtheria is treated as a medical emergency.
Is Diphtheria Antitoxin FDA Approved in the United States?
There is currently no routinely marketed U.S.-licensed DAT product.
CDC states that FDA authorizes CDC to distribute diphtheria antitoxin through an expanded access investigational new drug program, or EA-IND. (cdc.gov)
Healthcare professionals caring for a patient with suspected respiratory diphtheria work with their health department and CDC to obtain antitoxin.
Is Diphtheria Antitoxin Used for Skin Diphtheria?
Usually not.
CDC recommends DAT for respiratory diphtheria.
For uncomplicated cutaneous diphtheria, antibiotics are generally sufficient because systemic toxin complications are less common. (cdc.gov)
Which Antibiotics Treat Diphtheria?
Current CDC U.S. guidance recommends:
- Erythromycin
- Penicillin
for respiratory or cutaneous diphtheria. (cdc.gov)
CDC notes that substantial penicillin resistance has been reported in several regions, so antimicrobial susceptibility and geographic circumstances may influence treatment decisions.
Why Are Antibiotics Needed If Antitoxin Neutralizes the Toxin?
Antitoxin and antibiotics perform different jobs.
Antitoxin
Neutralizes circulating toxin.
Antibiotics
Kill or eliminate the bacteria producing the toxin.
Removing the bacteria:
- Stops additional toxin production
- Reduces transmission
- Helps eliminate carriage
Both are important for respiratory diphtheria.
Can Antibiotics Reverse Existing Heart or Nerve Damage?
No.
Antibiotics eliminate the bacterial source of toxin but do not undo cellular injury that has already occurred.
This is another reason early diagnosis and treatment matter.
What Supportive Treatment May Be Required?
Severe respiratory diphtheria may require:
- Hospitalization
- Airway monitoring
- Oxygen
- Intubation
- Tracheostomy in selected cases
- Mechanical ventilation
- Cardiac monitoring
- Treatment of heart failure
- Neurological monitoring
- Kidney support
- Intensive-care treatment
CDC recommends close monitoring for myocarditis and neuritis. (cdc.gov)
How Long Is Someone With Diphtheria Contagious?
Effective antibiotic treatment rapidly reduces infectiousness.
CDC notes that the disease is generally no longer contagious after approximately 48 hours of appropriate antibiotic therapy.
However, bacterial eradication should be confirmed.
After therapy is completed, CDC recommends obtaining two consecutive negative cultures at least 24 hours apart for toxigenic infections. (cdc.gov)
What Infection-Control Precautions Are Used?
For respiratory diphtheria:
Droplet precautions are recommended until treatment is completed and cultures confirm clearance.
For cutaneous diphtheria:
Contact precautions are recommended until clearance is documented. (cdc.gov)
What Happens to Close Contacts?
A suspected diphtheria case triggers a public-health investigation.
Close contacts may include:
- Household members
- Intimate contacts
- People exposed to respiratory secretions
- Certain healthcare workers
- People with significant direct exposure to infected wounds
CDC recommends management that can include:
- Quarantine for 7 to 10 days after the last exposure
- Monitoring for symptoms
- Nasal and throat cultures
- Antibiotic prophylaxis
- Review of vaccination status
- Additional vaccination when indicated
(cdc.gov)
Do Close Contacts Receive Antibiotics?
Yes.
CDC recommends prophylactic:
- Erythromycin
- Penicillin
for close contacts.
When adherence to a multi-day oral regimen is uncertain, intramuscular benzathine penicillin may be considered. (cdc.gov)
Do Fully Vaccinated Contacts Need Any Action?
Yes.
Vaccination does not replace the need for appropriate public-health evaluation.
Even vaccinated contacts may require:
- Cultures
- Monitoring
- Antibiotic prophylaxis
If the contact is otherwise up to date but received their last diphtheria-containing vaccine more than 5 years earlier, CDC recommends an additional vaccine dose following significant exposure. (cdc.gov)
Is There a Diphtheria Vaccine?
Yes.
Diphtheria is highly vaccine preventable.
The vaccine does not contain live C. diphtheriae bacteria.
Instead, it contains an inactivated form of diphtheria toxin known as:
diphtheria toxoid
The toxoid cannot cause diphtheria.
It teaches the immune system to produce antibodies capable of neutralizing diphtheria toxin if future exposure occurs. (cdc.gov)
Which Diphtheria Vaccines Are Used in the United States?
Diphtheria vaccination is given as part of combination vaccines.
The three principal types are:
- DTaP
- Tdap
- Td
(cdc.gov)
What Does DTaP Mean?
DTaP protects against:
Diphtheria Tetanus aP acellular pertussis
DTaP is used primarily in babies and children younger than 7 years.
What Does Tdap Mean?
Tdap protects against:
- Tetanus
- Diphtheria
- Acellular pertussis
It contains reduced quantities of certain antigens compared with pediatric DTaP.
Tdap is used in older children, adolescents, adults, and pregnancy.
What Does Td Mean?
Td protects against:
- Tetanus
- Diphtheria
It does not contain the pertussis component.
In the United States, CDC lists TENIVAC as a currently available Td product. (cdc.gov)
What Is the Childhood DTaP Schedule?
CDC recommends five DTaP doses during early childhood.
They are routinely given at:
- 2 months
- 4 months
- 6 months
- 15 through 18 months
- 4 through 6 years
(cdc.gov)
Childhood Diphtheria Vaccine Schedule
| Age | Vaccine |
|---|---|
| 2 months | DTaP dose 1 |
| 4 months | DTaP dose 2 |
| 6 months | DTaP dose 3 |
| 15 to 18 months | DTaP dose 4 |
| 4 to 6 years | DTaP dose 5 |
| 11 to 12 years | Tdap |
| Adulthood | Td or Tdap booster every 10 years |
Why Are So Many Doses Needed?
The initial vaccine series develops immunity.
Later doses strengthen and prolong that protection.
Because immunity to diphtheria toxin decreases with time, booster doses remain important throughout life.
What Vaccine Do Preteens Receive?
CDC recommends a routine Tdap dose at age 11 to 12 years. (cdc.gov)
Adolescents who missed the routine dose should receive catch-up vaccination.
Do Adults Need Diphtheria Vaccination?
Yes.
Diphtheria vaccination is not only for children.
CDC recommends that adults maintain protection through vaccination throughout life.
Adults who previously completed a primary vaccination series should receive:
Td or Tdap every 10 years
after receiving at least one Tdap dose. (cdc.gov)
What If an Adult Was Never Vaccinated?
Adults with no vaccination or an incomplete primary series generally need a three-dose primary series.
Current CDC adult guidance uses:
- Tdap
- Td or Tdap at least 4 weeks later
- Td or Tdap 6 to 12 months after the second dose
Routine Td or Tdap boosters are then given every 10 years. (cdc.gov)
Exact catch-up schedules should be determined using current CDC guidance.
Is Tdap Recommended During Pregnancy?
Yes.
CDC recommends one Tdap dose during every pregnancy, preferably during the early portion of gestational weeks:
27 through 36
(cdc.gov)
Although Tdap protects the mother against diphtheria and tetanus, the primary reason for giving it during each pregnancy is to transfer antibodies against pertussis to the baby before birth.
How Effective Is Diphtheria Vaccination?
CDC states that approximately 97 out of 100 people who are fully vaccinated are protected against diphtheria for up to about 10 years. (cdc.gov)
Protection gradually decreases, which is why boosters are needed.
Why Does Diphtheria Vaccination Target the Toxin?
The most dangerous effects of classic diphtheria are caused primarily by the toxin.
Vaccination therefore trains the immune system to produce antibodies that neutralize the toxin.
This means a vaccinated person’s immune system can respond quickly before the toxin causes major organ damage.
Can the Diphtheria Vaccine Cause Diphtheria?
No.
Diphtheria vaccines contain toxoid, not toxin-producing bacteria.
The toxin has been chemically inactivated so it cannot cause diphtheria.
What Are Common Vaccine Side Effects?
Depending on the vaccine formulation, common reactions can include:
- Injection-site pain
- Redness
- Swelling
- Mild fever
- Fatigue
- Irritability in children
- Headache
CDC reports that local reactions occur relatively commonly after DTaP and Tdap/Td vaccination, while serious reactions are uncommon. (cdc.gov)
Who Should Not Receive a Diphtheria-Containing Vaccine?
A severe allergic reaction such as anaphylaxis following a previous dose or to a vaccine component is a contraindication to further doses of the same relevant vaccine.
Certain neurological or other precautions relate particularly to the pertussis component of DTaP or Tdap.
CDC guidance can sometimes permit use of a Td-containing alternative when the pertussis component is contraindicated. (cdc.gov)
Is Natural Diphtheria Infection Better Than Vaccination?
No.
Natural infection can cause:
- Airway obstruction
- Heart damage
- Paralysis
- Kidney injury
- Death
It also may not reliably produce immunity.
Vaccination provides a much safer way for the immune system to learn how to neutralize diphtheria toxin.
How Can Diphtheria Be Prevented?
The most important prevention strategy is:
maintaining complete vaccination throughout life.
Additional measures during suspected cases include:
- Rapid diagnosis
- Isolation
- Antibiotic treatment
- Contact tracing
- Antibiotic prophylaxis for close contacts
- Cultures of exposed contacts
- Booster vaccination when needed
Why Does Community Vaccination Matter?
Diphtheria can spread efficiently when large numbers of people lack immunity.
High vaccination coverage makes it much harder for toxigenic C. diphtheriae to circulate.
When vaccination rates fall across several birth cohorts, susceptible populations accumulate.
This can eventually allow large outbreaks to occur.
What Is the Global Diphtheria Situation in 2026?
Diphtheria continues to circulate internationally.
WHO’s July 2026 fact sheet emphasizes that recent outbreaks demonstrate the continuing consequences of inadequate vaccination coverage.
WHO reported that in 2025:
- Approximately 85% of infants worldwide, about 110 million children, received the recommended three-dose primary diphtheria-containing series.
- Approximately 15% of infants, nearly 20 million children, remained unvaccinated or incompletely vaccinated.
- Only 83 countries included all three WHO-recommended diphtheria booster doses in national immunization programs.
- 42 countries had no diphtheria booster doses in their routine programs.
(who.int)
These immunity gaps help explain why outbreaks continue despite the existence of a highly effective vaccine.
Where Are Diphtheria Outbreaks Occurring?
As of CDC’s July 2026 surveillance update, diphtheria outbreaks were occurring in areas including:
- Haiti
- Parts of sub-Saharan Africa
- Australia
along with continued transmission in some other regions where diphtheria is endemic or immunization coverage is incomplete. (cdc.gov)
Travelers should ensure that their routine diphtheria vaccination is current before international travel.
Why Do Conflicts and Disasters Increase Diphtheria Risk?
Diphtheria vaccination requires:
- Primary childhood doses
- Booster doses
- Reliable healthcare access
Conflict and disasters can interrupt:
- Routine vaccination
- Vaccine supply
- Transportation
- Surveillance
- Laboratory testing
- Access to antitoxin
- Access to antibiotics
Overcrowded camps and displacement can then increase opportunities for transmission.
WHO identifies damaged health infrastructure, population displacement, overcrowding, and low vaccine coverage as major conditions that allow diphtheria outbreaks to develop. (who.int)
How Common Is Diphtheria in the United States?
Classic respiratory diphtheria is now very rare in the United States.
CDC attributes this largely to routine childhood vaccination and long-term population immunization.
A small number of travel-associated cutaneous cases have been identified in recent decades.
Diphtheria remains nationally notifiable, meaning suspected cases require prompt public-health reporting. (cdc.gov)
Has Respiratory Diphtheria Occurred in Modern U.S. Travelers?
Yes.
For example, in 2003 an unvaccinated Pennsylvania resident developed fatal respiratory disease after traveling to Haiti.
He developed severe airway disease followed by cardiac complications and died after 17 days of illness.
The case demonstrated that rare U.S. occurrence does not eliminate the risk to unvaccinated international travelers. (cdc.gov)
Is Diphtheria a Nationally Notifiable Disease?
Yes.
Suspected diphtheria should be reported promptly to the appropriate state or local health department.
Public-health officials coordinate:
- Laboratory confirmation
- Antitoxin access
- Isolation measures
- Contact tracing
- Antibiotic prophylaxis
- Vaccination of contacts
- Surveillance
(cdc.gov)
Is Diphtheria Eradicated?
No.
Diphtheria is controlled, not eradicated.
The bacteria continue circulating in parts of the world.
As long as susceptible populations remain, outbreaks can occur.
Can Diphtheria Be Eradicated in the Future?
Theoretically, controlling human C. diphtheriae transmission through extremely high global vaccination coverage would greatly reduce disease.
However, eradication is complicated by several factors:
- Immunity decreases over time
- Booster vaccination is required
- Asymptomatic carriage can occur
- Vaccination coverage differs between countries
- Healthcare disruptions create immunity gaps
- Related toxin-producing Corynebacterium species exist
Current public-health efforts therefore focus on maintaining high immunity and rapidly controlling outbreaks.
Is Diphtheria the Same as Strep Throat?
No.
Strep throat is usually caused by:
Group A Streptococcus
Diphtheria is caused mainly by toxin-producing C. diphtheriae.
Both diseases can cause:
- Sore throat
- Fever
- Swollen lymph nodes
- Throat abnormalities
However, diphtheria can produce an adherent pseudomembrane and systemic toxin effects that can damage the heart and nerves.
Laboratory testing helps distinguish them.
Is Diphtheria the Same as Tonsillitis?
No.
Tonsillitis simply means inflammation of the tonsils.
Many different viruses and bacteria can cause tonsillitis.
Diphtheria can involve the tonsils, but it is a specific toxin-mediated bacterial disease.
Is Diphtheria the Same as Croup?
No.
Both can affect the upper airway and cause breathing difficulties.
Croup is usually viral and commonly produces:
- Barking cough
- Hoarseness
- Stridor
Diphtheria is bacterial and can produce a tightly adherent pseudomembrane and systemic toxin complications.
Can Diphtheria Look Like Infectious Mononucleosis?
Yes.
Respiratory diphtheria can resemble several other illnesses.
CDC lists potential alternatives including:
- Group A streptococcal infection
- Staphylococcus aureus
- Candida
- Epstein-Barr virus
- Cytomegalovirus
- Adenovirus
- Herpes infections
(cdc.gov)
This is why travel history, vaccination history, membrane appearance, and laboratory testing are important.
Can Diphtheria Affect Adults?
Yes.
Diphtheria is not exclusively a childhood disease.
Before vaccination, children were most often affected because exposure frequently occurred early in life.
Today, adults whose immunity has declined because they missed booster vaccinations can also become susceptible.
Why Do Adults Need Boosters?
Antibody concentrations decline with time.
A person who completed childhood vaccination decades earlier may no longer have optimal protection.
CDC therefore recommends Td or Tdap vaccination every 10 years throughout adulthood. (cdc.gov)
Can Diphtheria Be Mild?
Yes.
Some infections are mild or asymptomatic.
However, mild infection still matters because infected people may transmit bacteria to someone who lacks immunity.
The severity of illness depends partly on:
- Toxin production
- Vaccination status
- Site of infection
- Amount of local disease
- Timing of treatment
- Age
- General health
Can Skin Diphtheria Become Serious?
Usually, cutaneous disease is less likely to cause severe systemic complications than respiratory diphtheria.
However, the wound can remain chronically infected and allow bacteria to spread to close contacts.
Some cutaneous infections involve toxigenic bacteria, which is why public-health evaluation and bacterial clearance remain important.
Can Diphtheria Cause Sudden Death?
Yes.
Severe airway obstruction can become immediately life-threatening.
Myocarditis can also produce dangerous arrhythmias or cardiac failure.
This is why a patient with suspected respiratory diphtheria requires urgent hospital assessment.
When Should Someone Seek Medical Care?
A person should seek prompt medical evaluation if they develop:
- Severe sore throat
- Difficulty swallowing
- Gray or white adherent throat membrane
- Neck swelling
- Hoarseness
- Recent close exposure to a diphtheria case
- Compatible illness after international travel
Tell the healthcare professional about:
- Vaccination history
- Recent countries visited
- Known diphtheria exposure
- Symptom onset date
- Respiratory difficulty
- Skin ulcers
When Is Diphtheria an Emergency?
Seek emergency medical care for:
- Difficulty breathing
- Stridor
- Severe neck swelling
- Bluish or gray skin
- Inability to swallow
- Rapidly increasing throat obstruction
- Chest pain
- Palpitations
- Fainting
- Severe weakness
- New paralysis
- Confusion
- Respiratory failure symptoms
Respiratory diphtheria can worsen quickly, and antitoxin treatment should not be delayed while waiting for final laboratory confirmation.
Frequently Asked Questions About Diphtheria
What causes diphtheria?
Classic diphtheria is caused primarily by toxin-producing strains of Corynebacterium diphtheriae.
Is diphtheria bacterial or viral?
Diphtheria is bacterial.
However, an interesting biological detail is that the bacterium usually gains its toxin-producing ability from a bacteriophage, a virus that infects bacteria.
What part of the body does diphtheria affect?
The most important site is the upper respiratory tract, including:
- Nose
- Tonsils
- Throat
- Larynx
Skin infections also occur.
What is the incubation period?
Symptoms generally develop approximately 2 to 5 days after exposure, with a possible range of roughly 1 to 10 days. (cdc.gov)
What is the most characteristic sign?
The hallmark of respiratory diphtheria is an adherent gray pseudomembrane in the respiratory tract. (cdc.gov)
Why is the membrane dangerous?
It can physically block the airway.
It also represents significant toxin-mediated local tissue destruction.
Why does the membrane bleed if removed?
The membrane is firmly attached to damaged underlying tissue.
Forceful removal can tear this tissue and cause bleeding.
What is bull neck?
Bull neck describes severe swelling of the neck caused by extensive local inflammation and enlarged lymph nodes.
Is diphtheria contagious?
Yes.
Toxigenic C. diphtheriae spreads primarily through respiratory droplets and close contact.
Can someone spread diphtheria without being sick?
Yes.
Asymptomatic carriers can transmit the bacteria.
How long is someone contagious?
Appropriate antibiotics rapidly decrease transmission risk.
CDC recommends confirming elimination with two negative cultures obtained after treatment. (cdc.gov)
Can diphtheria cause heart disease?
Yes.
Diphtheria toxin can cause myocarditis and dangerous abnormal heart rhythms.
Can diphtheria cause paralysis?
Yes.
The toxin can damage nerves and produce weakness or paralysis.
Can diphtheria damage the kidneys?
Yes.
Kidney injury or kidney failure can occur in severe disease.
How deadly is diphtheria?
CDC estimates an overall case-fatality rate of approximately 5% to 10%.
Mortality can approach 20% among young children and adults over 40. (cdc.gov)
Can untreated diphtheria be more dangerous?
Yes.
WHO estimates that among unvaccinated people without proper treatment, fatality can be approximately 30%. (who.int)
What is diphtheria antitoxin?
It is an antibody preparation that neutralizes circulating diphtheria toxin.
Does antitoxin kill the bacteria?
No.
Antibiotics eliminate the bacteria.
Antitoxin neutralizes circulating toxin.
Why must antitoxin be given quickly?
It cannot reverse toxin that has already bound to body tissues.
Early administration therefore provides the greatest potential benefit.
Is antitoxin available in the United States?
Yes, but it is not routinely sold as a standard licensed U.S. product.
CDC distributes DAT under an FDA-authorized expanded access investigational protocol. (cdc.gov)
Which antibiotics treat diphtheria?
Current CDC guidance recommends erythromycin or penicillin. (cdc.gov)
Do antibiotics alone treat respiratory diphtheria?
Antibiotics are necessary but do not replace antitoxin when toxin-producing respiratory diphtheria is suspected.
Does diphtheria require hospitalization?
Suspected respiratory diphtheria generally requires urgent hospital evaluation because of the risks of airway obstruction, myocarditis, and neurological complications.
Is there a diphtheria vaccine?
Yes.
Diphtheria toxoid is included in DTaP, Tdap, and Td vaccines.
Does the vaccine contain live bacteria?
No.
The key diphtheria component is an inactivated toxin called a toxoid.
Can the vaccine cause diphtheria?
No.
Diphtheria toxoid cannot cause diphtheria disease.
How many DTaP doses do children receive?
The routine childhood schedule contains five doses:
- 2 months
- 4 months
- 6 months
- 15 through 18 months
- 4 through 6 years
(cdc.gov)
When is Tdap given?
A routine Tdap dose is recommended at 11 to 12 years.
Adults who have never received Tdap should receive one according to CDC guidance.
Do adults need boosters?
Yes.
CDC recommends Td or Tdap every 10 years throughout adulthood after the appropriate primary series. (cdc.gov)
Is Tdap recommended during pregnancy?
Yes.
CDC recommends Tdap during every pregnancy, preferably during the early portion of weeks 27 through 36.
Can someone who already had diphtheria skip vaccination?
No.
Natural disease does not reliably provide immunity.
Vaccination status should be reviewed after recovery. (cdc.gov)
Is diphtheria still present worldwide?
Yes.
Outbreaks continue to occur, particularly where vaccination coverage is inadequate.
Is diphtheria common in the United States?
No.
It is now very rare because of widespread vaccination.
Can travelers still get diphtheria?
Yes.
Travelers who are not adequately vaccinated can become infected in places where the bacteria continue circulating.
Is diphtheria eradicated?
No.
The disease remains present globally.
Why do outbreaks still happen if a vaccine exists?
Outbreaks can occur when:
- Children miss routine doses
- Adults miss boosters
- Healthcare systems collapse
- Conflict interrupts immunization
- Populations are displaced
- Communities become overcrowded
- Vaccine coverage remains low for several years
How many children worldwide receive diphtheria vaccination?
WHO estimated that approximately 85% of infants worldwide received three doses of diphtheria-containing vaccine in 2025. (who.int)
That still leaves millions of children incompletely protected.
Why Diphtheria Is Important in the History of Medicine
Diphtheria is now rare in highly vaccinated countries, which can make it easy to underestimate how important the disease has been to medicine.
For centuries, physicians watched children develop throat membranes, struggle for air, become paralyzed, develop heart complications, and die.
There was no reliable explanation and no specific treatment.
That changed rapidly during the late nineteenth century.
Edwin Klebs observed the responsible bacterium in 1883.
Friedrich Löffler cultivated it in 1884 and proposed that a soluble poison produced the distant organ damage.
Émile Roux and Alexandre Yersin demonstrated the toxin experimentally in 1888.
Then came an extraordinary breakthrough.
Emil von Behring and other early immunologists discovered that serum containing antitoxin could neutralize diphtheria toxin.
The discovery helped establish the concepts of:
- Antibodies
- Passive immunity
- Serum therapy
Von Behring received the first Nobel Prize in Physiology or Medicine in 1901 for this work. (nobelprize.org)
Diphtheria research did not stop there.
Scientists learned how to chemically inactivate the toxin while retaining its ability to stimulate immunity.
The resulting diphtheria toxoid became one of the great vaccine achievements of the twentieth century.
Mass immunization beginning in the 1930s and 1940s changed diphtheria from a routine childhood threat into a rare disease in countries with sustained vaccination programs. (cdc.gov)
Yet diphtheria has never disappeared.
It repeatedly returns when vaccination coverage falls.
The global situation in 2026 illustrates that reality.
WHO estimates that nearly 20 million infants in 2025 received no diphtheria vaccination or did not complete the recommended three-dose primary series. Many countries also lack the full booster schedule needed to maintain protection throughout childhood and adolescence. (who.int)
That matters because immunity decreases with time.
Protection against diphtheria requires more than developing a vaccine once.
It requires maintaining vaccination programs generation after generation.
Modern diphtheria prevention therefore depends on several interconnected strategies:
- Routine childhood vaccination
- Adolescent Tdap vaccination
- Adult booster vaccination
- Tdap during every pregnancy
- Rapid identification of suspected disease
- Immediate diphtheria antitoxin for suspected respiratory cases
- Appropriate antibiotic treatment
- Isolation
- Contact tracing
- Antibiotic prophylaxis for close contacts
- Vaccination of under-immunized contacts
- Strong global immunization programs
Diphtheria provides one of the clearest examples of the difference between a controlled disease and an eradicated disease.
Vaccination has made diphtheria almost invisible in many countries.
But the organism still exists.
When vaccination weakens, the disease can return.
For that reason, the enormous historical success of diphtheria vaccination is not a reason to stop vaccinating. It is evidence of why vaccination must continue.
More than a century after antitoxin transformed diphtheria treatment and decades after toxoid vaccines transformed prevention, the central medical lesson remains remarkably consistent:
recognize respiratory diphtheria early, neutralize the toxin quickly, eliminate the bacteria, protect exposed contacts, and maintain vaccination throughout life.
Medical, vaccine, treatment, historical, and epidemiological information reviewed against CDC, WHO, NIH, and Nobel Prize historical resources available through September 2026.